Nima Sharifi, MD of Cleveland Clinic discusses the new Androgen Receptor Signaling and the new targets and agents for advanced prostate cancer at ASCO GU 2016 in San Francisco.
Advertisement
[the_ad id="32629"]
New Androgen Receptor Signaling and the new targets and agents for advanced prostate cancer
By Editor